Efgartigimod with recombinant human hyaluronidase PH20 for treating chronic inflammatory demyelinating polyneuropathy [ID6409]

  • In development
  • GID-TA11508
  • Expected publication date: 

NIHRIO BN: 29647-Efgartigimod-PH20-SC-for-Chronic-Inflammatory-Demyelinating-Polyradiculoneuropathy-V1.0-DEC2023-NON-CONF.pdf (nihr.ac.uk)